VeedmaTools
Internal · not public

How we work

How a tool goes from idea to live, the independent resources we point readers to for learning more, and how every piece of content gets gated for compliance.

Workflow 01

Shipping a new tool

Every tool follows the same path. The rule underneath it: educate and screen, never diagnose or promise, and never ship a claim we can't source.

  1. Start with real usefulness

    The first test: would this genuinely help someone on its own, even if they never become a customer? If it is marketing dressed up as a tool, we do not build it. Medical-grade and useful, never fluff.

  2. Ground it in a validated method

    Start from a published instrument or equation (Vermeulen, ADAM), not invented logic. Research the exact wording and cite the primary source.

  3. Build it right

    Astro + the design system. Runs client-side, stores nothing, accessible (labels, focus, keyboard), and honest about its own limits.

  4. Cite every claim

    Numbered inline citations linking to a Sources list (Wikipedia/Veedma style). See compliance/citation-style.md. No "trust me" science.

  5. Run the compliance gate

    Risk-tier it, run the AI pre-check, then a human verifies sources and FTC/FDA framing and signs off. See Workflow 03 below.

  6. Ship

    Flip the tool's status to live in src/data/tools.js and add its href. It appears in the catalog automatically.

  7. Re-review on a schedule

    Each approved tool carries a re-review date (default 12 months, sooner if the underlying science changes). Logged in compliance/review-log.md.

Community & education

Where to learn more

Our tools are a starting point, not the whole story. These are credible, independent resources for going deeper on testosterone and hormone health. We are not affiliated with any of them. Follow the evidence, not the hype.

Start with the primary sources

Endocrine Society guideline

Bhasin et al., 2018

The clinical standard for diagnosing and treating low testosterone.

PubMed

pubmed.ncbi.nlm.nih.gov

Read the primary research yourself, instead of a secondhand summary.

Independent educators worth your time

Dr. Rena Malik

Urologist · YouTube

Evidence-first myth-busting on testosterone, the labs that matter, and sexual health.

Dr. Justin Houman

Urologist · YouTube / Instagram

Plain-language explainers on enclomiphene vs TRT, fertility, and free testosterone.

Dr. Mohit Khera

Baylor urologist

Academic authority on testosterone therapy, safety data, and guidelines.

Dr. Ranjith Ramasamy

Univ. of Miami

Fertility-preserving approaches to low T, straight from the research.

For deeper clinical background, see Veedma's low-testosterone knowledge base. The AUA Testosterone Deficiency Guideline (2018) is another authoritative reference.

Workflow 03

Compliance system

A lightweight version of pharma's MLR (Medical-Legal-Regulatory) review. The rule: no claim goes public without being checked against the rules, tied to a source, and signed off by a human. Detail in compliance/.

FTC truth-in-advertising FDA: no off-label drug claims HIPAA / privacy No diagnosis Cited claims

  1. Draft & self-annotate

    List every claim with its source. No source, no claim. Reuse compliance/claims-library.md.

  2. Assign a risk tier

    Tier 1 (no health claims) · Tier 2 (educational tools) · Tier 3 (anything implying an outcome, diagnosis, drug, or a testimonial → counsel).

  3. AI pre-check

    Run the copy through compliance/review-prompt.md. Treat the output as suspicions to verify, never a verdict.

  4. Human decision

    A person verifies every cited source opens and says what we claim (catches AI-invented citations) and judges the FTC/FDA framing.

  5. Sign off & log

    Record Pass / Pass-with-changes / Fail with a name and date in compliance/review-log.md. That record is the approval. A clean AI pass is not.

Not legal advice. This workflow reduces risk and builds a defensible record. Off-label drug speech, HIPAA classification, and state telehealth rules still need a healthcare/advertising attorney.